关于与桦川县人民政府签订中药、原料药基地建设项目框架协议的公告 共 6 页 证券代码：000931 证券简称：中关村 公告编号：2026-016 北京中关村科技发展（控股）股份有限公司 关于与桦川县人民政府签订中药、原料药基地建设项目 框架协议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 2、本次合作相关事宜仅为双方对合作方式、领域达成的初步意向，具体的 实施内容、进度以及投资回报尚存在不确定性，对公司当期及未来业绩的影响尚 无法判断。 3、公司最近三年披露的框架协议或意向性协议的进展情况详见"六、其他 相关说明"。 一、协议签署概述 北京中关村科技发展（控股）股份有限公司（以下简称：公司）与黑龙江省 佳木斯市桦川县人民政府（以下简称：桦川县人民政府）于 2026 年 2 月 6 日在 北京市签订《中药、原料药基地建设项目框架协议》，公司契合国家"医药大健 康"产业发展战略，为提升中药、原料药产业生产能力，进一步增强核心竞争力， 计划在黑龙江省佳木斯市桦川县建设现代化数字化工厂，打造行业领先水平的中 药、原料药生产制造基地。资金来源主要为公司自筹资金 ...

Core Insights - The AI + Energy Development Conference held in Beijing focused on the integration of artificial intelligence with the energy sector, emphasizing the importance of this fusion for achieving high-quality development in the energy industry and supporting the construction of a strong energy nation [1][4][20] Group 1: Conference Overview - The conference gathered over 300 representatives from government, energy companies, and industry experts to discuss the deep integration of AI and the energy sector [1][3] - Various organizations co-hosted the event, including the China Energy News and the China Energy Conservation Association, highlighting a collaborative effort towards achieving carbon neutrality and energy transformation [3][4] Group 2: Strategic Importance of AI in Energy - Leaders emphasized that AI's integration into the energy sector is crucial for transitioning to a smart, green, and low-carbon energy system, which is essential for building a new energy framework [4][5] - The conference aimed to serve as a platform for innovative ideas, cross-industry collaboration, and to provide insights for policymakers and industry practitioners [4][6] Group 3: AI Market Potential - The Haidian District, as a core area for international technological innovation in Beijing, is projected to have an AI market size of 360 billion by 2025, with 1,900 AI core enterprises [5] - The district plans to focus on three main areas to promote AI + Energy development: creating AI energy clusters, accelerating AI applications in energy scenarios, and building an innovation ecosystem [5] Group 4: Expert Insights - Experts highlighted that AI is not merely a technological addition but a transformative force that can reshape the global competitive landscape in the energy sector [6][8] - The integration of AI and green energy is seen as a significant driver for economic development, with applications in smart grids, energy management, and storage optimization [6][9] Group 5: Practical Applications and Challenges - Companies like State Power Investment Corporation and HaiCheng Storage shared their experiences in applying AI to enhance production efficiency and operational safety in energy storage [13] - Challenges such as data quality, standardization, and the need for skilled personnel in AI and energy sectors were identified as critical issues that need addressing for successful integration [16][19] Group 6: Future Directions - The conference concluded with actionable initiatives, including the launch of the AI + Energy Green Industry Tour and the establishment of the AI Digital Energy Industrial Park [18][20] - The ongoing collaboration between industry, academia, and government is expected to facilitate the practical application of AI in the energy sector, contributing to China's energy goals and global green transformation [20]

来源：北 京日报客户端 近日，2026中关村论坛系列活动——第九届中关村国际前沿科技大赛金融科技领域复赛在中关村（西 城）金融科技特色产业园新动力金融科技中心举办。 比赛现场，来自高校院所、投资机构、相关企业的多位专家受邀担任评委，针对路演表现和发展前景进 行现场打分，并对项目未来的发展方向提出了建设性意见和建议。 中关村国际前沿科技大赛创设于2017年，把握全球科技革命和产业变革方向，密切跟踪前沿科技发展趋 势，按照"全球邀约、自由探索、公开路演"的方式，搭建高水平国际前沿科技交流竞技平台。本届大赛 共设立AI底层技术、AI应用、创新药、医疗器械、新材料、文化科技、金融科技等七个参赛领域，共 征集境内外项目2168项，其中金融科技领域申报198项，经初赛评审后共有25个项目进入复赛，涉及区 块链与分布式账本应用、数智化金融营销、金融数据安全与合规技术、支付欺诈实时防火墙系统等多个 技术方向。 最终，面向金融的超快速数据传输解决方案、桔吉机器人会计等10个项目脱颖而出，获得第九届中关村 国际前沿科技大赛金融科技领域TOP10荣誉称号。 SEX 117 公司概况-全国布局 IT 提供专业。迅捷、可信赖的全生食用 ...

创新氛围日益浓厚、科技属性日益凸显、"城"的功能越来越完善——近5年来，天津市宝坻区坚持以京 津冀协同发展为战略牵引，举全区之力建设宝坻京津中关村科技城，为区域高质量发展注入了强劲动 能。 2025年，京津中关村科技城工业总产值、限上批零销售额、固定资产投资、税收同比分别增长14%、 79.8%、35.6%、24.3%，带动宝坻全区发展迈上新台阶——2025年宝坻区地区生产总值增长5.1%，规上 工业增加值增速位列天津市重点工业十区第一，一般公共预算收入增长19.7%，主要经济指标增速位居 天津市前列。目前，该科技城国高新企业达32家，经营主体总数突破2000家。 宝坻区委书记毛劲松告诉记者，2025年7月，京津中关村科技城被纳入天开高教科创园"一核两翼多 点"空间发展布局，成为京津冀区域首个既有中关村发展集团重资产投入，又有天开园创新基因注入的 载体平台。围绕建好用好京津中关村科技城这个全区重要工程，宝坻区正抢抓新一轮科技革命和产业变 革深入发展机遇，加快推动产业优势、科技优势、人才优势转化为现实生产力；以推进京津冀协同发展 为战略牵引，以更开放的思维、体制、平台，集聚更多资源要素。 2025年，天津市标志 ...

Core Viewpoint - Zhongguancun announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd., has received the Acceptance Notice from the National Medical Products Administration for the consistency evaluation application of Sodium Cytidine Injection [2] Group 1 - Duoduo Pharmaceutical's application for the consistency evaluation of Sodium Cytidine Injection has been officially accepted [2]

中关村2025年三季报显示，前三季度公司主营收入18.82亿元，同比下降2.46%；归母净利润4949.14万 元，同比下降4.14%；扣非净利润4364.42万元，同比上升8.99%；其中2025年第三季度，公司单季度主 营收入6.44亿元，同比下降1.96%；单季度归母净利润1068.25万元，同比下降29.9%；单季度扣非净利 润678.93万元，同比下降47.83%；负债率51.09%，投资收益-168.26万元，财务费用3613.22万元，毛利 率59.64%。中 关 村（000931）主营业务：业务主要分为生物医药及健康品业务、养老医疗业务、商砼 业务和其他业务。其中:1、生物医药及健康品业务包括化学药、中药、健康品和医疗器械业务,主要从 事外用制剂、片剂、注射剂、胶囊、口服溶液剂、颗粒剂、原料药、麻醉药品及二类精神药品的研发、 制造与销售;药品临床前研究服务及药品一致性评价研究服务;医疗设备、试剂和相关耗材的销售及服务 业务;口腔清洁用品的研发、生产与销售;2、养老医疗业务主要包括集中养老服务、居家养老服务、健 康管理、健康咨询、预防保健咨询、中医医疗服务、养老旅居业务以及依托实体医院的互联网医 ...

Core Viewpoint - The announcement indicates that Duoduo Pharmaceutical Co., Ltd. has received a notice of acceptance from the National Medical Products Administration for the consistency evaluation application of Sodium Cytidine Injection, marking a significant step in the drug's regulatory process [1] Group 1: Product Information - The drug in question is Sodium Cytidine Injection, with a specification of 2ml:0.25g (calculated as C14H26N4O11P2) [1] - The application pertains to the consistency evaluation for domestically produced drugs, which is crucial for ensuring quality and efficacy [1] Group 2: Historical Context - Sodium Cytidine Injection was approved for market release in 1987, with the approval number Guo Yao Zhun Zi H19993355 [1] - The drug is indicated for conditions such as cerebral blood supply disorders due to thrombosis or vascular rupture, particularly during acute and subacute phases, as well as for traumatic brain injuries [1] Group 3: Financial Investment - As of the date of the announcement, the project has accumulated research and development expenses totaling 2.4575 million yuan [1]

Core Viewpoint - Zhongguancun (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd., has received the Acceptance Notice from the National Medical Products Administration for the consistency evaluation application of Sodium Cytidine Injection [1] Group 1: Product Information - The product under application is indicated for: 1) Cerebral blood supply disorders during the acute and subacute phases caused by thrombosis or vascular rupture 2) Conditions resulting from head trauma due to impact [1]

Core Viewpoint - The company Zhongguancun (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd., has received an acceptance notice from the National Medical Products Administration for the consistency evaluation application of sodium cytidine injection [1] Group 1 - The product under application is indicated for: 1) cerebral blood supply disorders during acute and subacute phases caused by thrombosis or vascular rupture 2) conditions resulting from head trauma due to impact [1]

Core Viewpoint - Zhongguancun (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd., has received the Acceptance Notice from the National Medical Products Administration for the consistency evaluation application of Sodium Oligodendrocyte Injection [1] Group 1: Product Information - The Sodium Oligodendrocyte Injection (specification: 2ml:0.25g, calculated as C14H26N4O11P2) was approved for market launch in 1987, with the drug approval number Guoyao Zhunzi H19993355 [1] - The indications for the newly submitted product include: 1) Cerebral blood supply disorders during acute and subacute phases caused by thrombosis or vascular rupture; 2) Conditions resulting from head trauma [1]